https://www.lipid.org/resource/cac-scoring-mar-2022/ 2026-08-19T15:30:51+00:00 https://www.lipid.org/resource/apoe-what-lipidologists-need-to-know-and-what-they-were-never-taught-may-2023/ 2026-08-19T15:30:11+00:00 https://www.lipid.org/resource/address-ascvd-risk-in-south-asians-living-in-the-us/ 2026-08-19T15:29:53+00:00 https://www.lipid.org/resource/risk-assessment-tools-and-dietary-questionnaires/ 2026-08-18T17:33:18+00:00 https://www.lipid.org/wp-content/uploads/EBM-A.png https://www.lipid.org/wp-content/uploads/EBM-B.png https://www.lipid.org/wp-content/uploads/EBM-C.png https://www.lipid.org/wp-content/uploads/EBM-D.png https://www.lipid.org/resource/lipid-measurements-in-the-management-of-cardiovascular-diseases-practical-recomendations/ 2026-08-18T17:30:39+00:00 https://www.lipid.org/resource/s2e1-omega-3-outcome-trials-in-perspective-part-2/ 2026-08-18T16:47:47+00:00 https://www.lipid.org/resource/how-we-do-it-lipid-specialists-pushing-boundaries-to-improve-patient-care-across-a-variety-of-practice-settings/ 2026-08-13T19:17:22+00:00 https://www.lipid.org/wp-content/uploads/IMG_9573-0031.jpg https://www.lipid.org/wp-content/uploads/CF-1.png https://www.lipid.org/wp-content/uploads/iStock-1293927048.jpg https://www.lipid.org/wp-content/uploads/iStock-1364551940.jpg https://www.lipid.org/wp-content/uploads/iStock-1402004971.jpg https://www.lipid.org/resource/polyphenols-protective-effects/ 2026-08-13T19:15:57+00:00 https://www.lipid.org/wp-content/uploads/Practical-Pearls.jpg.jpeg https://www.lipid.org/resource/access-issues-in-rural-healthcare-and-opportunities-for-improvement/ 2026-08-13T19:15:26+00:00 https://www.lipid.org/wp-content/uploads/unnamed.jpg https://www.lipid.org/wp-content/uploads/unnamed.png https://www.lipid.org/wp-content/uploads/unnamed-1.jpg https://www.lipid.org/wp-content/uploads/unnamed-2.jpg https://www.lipid.org/wp-content/uploads/unnamed-3.jpg https://www.lipid.org/resource/effects-of-low-cholesterol-on-adrenal-function/ 2026-08-13T19:13:27+00:00 https://www.lipid.org/wp-content/uploads/Specialty-Corner-Figure-1.jpg https://www.lipid.org/wp-content/uploads/Specialty-Corner-Figure-2.jpg https://www.lipid.org/resource/elevated-ldl-secondary-to-multiple-myeloma/ 2026-08-13T19:11:15+00:00 https://www.lipid.org/wp-content/uploads/Patient-lab-results.png https://www.lipid.org/wp-content/uploads/Patient-LDL-cholesterol-trends.png https://www.lipid.org/wp-content/uploads/Patient-protein-studies.png https://www.lipid.org/resource/nonalcoholic-fatty-liver-disease-the-hepatic-complication-of-metabolic-dysmetabolism/ 2026-08-13T19:10:32+00:00 https://www.lipid.org/wp-content/uploads/2020-MWLA-Lipid-Spin-online-4_Page_08_Image_0003.jpg https://www.lipid.org/wp-content/uploads/2020-MWLA-Lipid-Spin-online-4_Page_09_Image_0001.jpg https://www.lipid.org/wp-content/uploads/Multiple-Causes.png https://www.lipid.org/wp-content/uploads/Management-of-NAFLD.png https://www.lipid.org/wp-content/uploads/Drugs-in-Development-to-Treat-NASH.png https://www.lipid.org/resource/myths-and-misunderstandings-the-rationale-and-evidence-for-the-screening-and-treatment-of-pediatric-dyslipidemia/ 2026-08-13T19:08:50+00:00 https://www.lipid.org/wp-content/uploads/lipid-img4.jpg https://www.lipid.org/wp-content/uploads/Figure-1.-Trends-in-pediatric-lipid-screening-recommendations-over-time.jpg https://www.lipid.org/resource/tuberous-and-tendon-xanthomas-dont-overlook-sitosterolemia-or-cerebrotendinous-xanthomatosis/ 2026-08-13T19:08:05+00:00 https://www.lipid.org/wp-content/uploads/Guest-Editorial-Table-1-2015.png https://www.lipid.org/wp-content/uploads/Guest-Editorial-Figure-1-2015.png https://www.lipid.org/wp-content/uploads/Guest-Editorial-Table-2.png https://www.lipid.org/resource/firefighters-and-cvd-heroes-with-hearts-at-risk/ 2026-08-13T19:06:28+00:00 https://www.lipid.org/wp-content/uploads/firefighter.png https://www.lipid.org/wp-content/uploads/table1-34.png https://www.lipid.org/wp-content/uploads/table2-34.png https://www.lipid.org/resource/lipid-measurements-in-the-management-of-cardiovascular-diseases-practical-recommendations-a-scientific-statement-from-the-national-lipid-association-writing-group/ 2026-08-13T18:57:12+00:00 https://www.lipid.org/resource/use-of-lipoproteina-in-clinical-practice-a-biomarker-whose-time-has-come-a-scientific-statement-from-the-national-lipid-association/ 2026-08-13T18:56:57+00:00 https://www.lipid.org/resource/navigating-barriers-in-familial-hypercholesterolemia-journey-a-tale-of-resilience-and-advocacy/ 2026-08-13T18:56:14+00:00 https://www.lipid.org/resource/nutrition-interventions-for-youth-with-dyslipidemia-a-national-lipid-association-clinical-perspective/ 2026-08-13T18:41:38+00:00 https://www.lipid.org/resource/lipid-metabolism-and-cardiovascular-disease-in-patients-with-renal-disease/ 2026-08-13T18:40:27+00:00 https://www.lipid.org/resource/the-young-active-asymptomatic-patient-with-very-high-ldl-c/ 2026-08-13T16:47:45+00:00 https://www.lipid.org/resource/s1e4-special-edition-new-lipid-therapies/ 2026-08-13T16:40:39+00:00 https://www.lipid.org/resource/s7e1-changing-the-fh-playbook-diagnosis-and-treatment-updates-from-the-nla/ 2026-08-13T16:39:25+00:00 https://www.lipid.org/resource/ldl-cholesterol-management-simplified-in-adults-lower-for-longer-is-better-guidance-from-the-national-lipid-association/ 2026-08-13T16:32:09+00:00 https://www.lipid.org/resource/practical-approaches-to-dietary-management-of-hypertriglyceridemia/ 2026-08-13T16:02:20+00:00 https://www.lipid.org/wp-content/uploads/EBM-1.png https://www.lipid.org/wp-content/uploads/EBM21.jpg https://www.lipid.org/resource/nla-scientific-statement-on-statin-intolerance-a-new-definition-and-key-considerations-for-ascvd-risk-reduction-in-the-statin-intolerant-patient/ 2026-08-13T15:59:29+00:00 https://www.lipid.org/resource/womens-health-guidelines-for-lipid-lowering-in-women-what-have-we-learned/ 2026-08-13T15:44:02+00:00 https://www.lipid.org/wp-content/uploads/Optimizing-risk.png https://www.lipid.org/wp-content/uploads/Cardiovascular-Risk-Factors-Specific-to-Women.png https://www.lipid.org/wp-content/uploads/Comparison-of-Various-Lipid-Lowering-Guidelines-for-Women.png https://www.lipid.org/resource/north-american-familial-chylomicronemia-syndrome-nafcs-scoring-tools/ 2026-08-12T18:48:10+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/origins-of-the-nla/ 2026-08-12T18:47:17+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/the-significance-of-nla-scientific-statements-and-clinical-perspectives/ 2026-08-12T18:47:03+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/a-new-vision-for-the-nla/ 2026-08-12T18:46:51+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/nlas-future-education-endeavors/ 2026-08-12T18:46:43+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/the-future-of-nla-scientific-statements-to-infinity-and-beyond/ 2026-08-12T18:46:35+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/the-meaning-of-mentorship/ 2026-08-12T18:46:27+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/past-and-future-of-the-journal-of-clinical-lipidology/ 2026-08-12T18:46:18+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/legacy-and-outlook-of-lipidspin/ 2026-08-12T18:46:10+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/expanding-projects-and-popularity-foundation-of-the-nla/ 2026-08-12T18:45:54+00:00 https://www.lipid.org/resource/lipid-spin/summer-2022/times-of-new-technology-therapies/ 2026-08-12T17:55:17+00:00 https://www.lipid.org/resource/review-of-current-evidence-and-clinical-recommendations-on-the-effects-of-low-carbohydrate-and-very-low-carbohydrate-including-ketogenic-diets-for-the-management-of-body-weight-and-other-cardiometab/ 2026-08-12T17:47:20+00:00 https://www.lipid.org/resource/the-lipid-panel-ldl-cholesterol-management-simplified-in-adults-sep-2025/ 2026-08-12T17:32:45+00:00 https://www.lipid.org/resource/practical-pearls-lipids-in-women-in-reproductive-years-sep-2025/ 2026-08-12T17:31:26+00:00 https://www.lipid.org/resource/the-lipid-panel-the-role-of-apolipoprotein-b-in-clinical-management-of-adults-nov-2024/ 2026-08-12T17:28:18+00:00 https://www.lipid.org/resource/cardiovascular-imaging-use-to-assess-risk-jul-2023/ 2026-08-12T17:25:48+00:00 https://www.lipid.org/resource/genetic-testing-in-dyslipidemia-a-scientific-statement-from-the-national-lipid-association/ 2026-08-12T17:24:48+00:00 https://www.lipid.org/resource/s1e1-clinical-pearls-on-provider-methods-for-obtaining-prior-authorizations-for-pcsk9i/ 2026-08-12T15:12:42+00:00 https://www.lipid.org/resource/dyslipidemia-management-in-women-of-reproductive-potential-an-expert-clinical-consensus-from-the-national-lipid-association/ 2026-08-11T21:11:27+00:00 https://www.lipid.org/resource/s6-lipid-snippet-polygenic-risk-score-for-coronary-artery-disease-predicts-ascvd-in-fh/ 2026-08-11T20:42:19+00:00 https://www.lipid.org/resource/lipoprotein-x-in-graft-versus-host-disease-of-the-liver/ 2026-08-11T18:21:47+00:00 https://www.lipid.org/wp-content/uploads/f-37-1.jpg https://www.lipid.org/wp-content/uploads/f-38-1.jpg https://www.lipid.org/resource/can-coronary-artery-disease-be-prevented-lessons-learned-from-ancient-mummies-to-the-contemporary-tsimane-of-the-bolivian-amazon/ 2026-08-11T18:21:01+00:00 https://www.lipid.org/wp-content/uploads/f-1.jpg https://www.lipid.org/wp-content/uploads/f-2.jpg https://www.lipid.org/wp-content/uploads/Figure-3.png https://www.lipid.org/wp-content/uploads/f-4.jpg https://www.lipid.org/wp-content/uploads/f-5.jpg https://www.lipid.org/wp-content/uploads/f-6.jpg https://www.lipid.org/resource/current-understanding-of-the-contribution-of-lipoproteina-to-atherosclerotic-cardiovascular-disease-risk-in-women/ 2026-08-11T18:19:28+00:00 https://www.lipid.org/wp-content/uploads/GuestEd_Figure1.png https://www.lipid.org/resource/icd-10-codes/ 2026-08-06T20:37:59+00:00 https://www.lipid.org/resource/what-clinicians-need-to-know-about-bempedoic-acid/ 2026-08-04T21:33:02+00:00 https://www.lipid.org/resource/working-with-patients-following-very-low-carbohydrate-and-or-ketogenic-diets-oct-2021/ 2026-08-04T21:31:44+00:00 https://www.lipid.org/resource/the-lipid-panel-beta-sitosterolemia-and-sterol-absorption-nov-2022/ 2026-08-04T21:30:17+00:00 https://www.lipid.org/resource/the-lipid-panel-statins-and-intracerebral-hemorrhage-apr-2023/ 2026-08-04T21:26:49+00:00 https://www.lipid.org/resource/episode-6-industry-innovations-guidelines-in-action/ 2026-08-03T14:01:15+00:00 https://www.lipid.org/resource/obesity-therapy-role-for-glp-1-agonists-mar-2023/ 2026-07-29T12:52:12+00:00 https://www.lipid.org/resource/episode-5-statin-intolerance-in-focus-navigating-side-effects-patient-concerns-and-the-path-to-optimal-ldl-lowering/ 2026-07-28T15:23:59+00:00 https://www.lipid.org/resource/s7e8-thinking-long-term-ldl-exposure-longevity-medicine-and-the-future-of-cardiovascular-prevention/ 2026-07-23T15:53:41+00:00 https://www.lipid.org/resource/ldl-c-management-simplified-in-adults-guidance-from-the-national-lipid-association/ 2026-07-22T15:36:07+00:00 https://www.lipid.org/resource/familial-hypercholesterolemia-screening-diagnosis-and-management-of-pediatric-and-adult-patients/ 2026-07-22T15:33:41+00:00 https://www.lipid.org/resource/the-readiness-to-change-conversation/ 2026-07-22T15:30:34+00:00 https://www.lipid.org/resource/balance-new-triglyceride-lowering-drugs-nov-2024/ 2026-07-22T14:12:40+00:00 https://www.lipid.org/resource/the-5-minute-nutrition-counseling-guide/ 2026-07-22T14:12:10+00:00 https://www.lipid.org/resource/obicetrapib-update-mar-2024/ 2026-07-22T14:10:07+00:00 https://www.lipid.org/resource/the-lipid-panel-imaging-is-my-treatment-working-dec-2022/ 2026-07-22T14:02:22+00:00 https://www.lipid.org/resource/the-lipid-panel-chylomicronemia-jan-2023/ 2026-07-22T13:56:33+00:00 https://www.lipid.org/resource/diabesity-apr-2024/ 2026-07-22T13:54:56+00:00 https://www.lipid.org/resource/setting-smart-goals-with-your-patients/ 2026-07-21T14:03:09+00:00 https://www.lipid.org/resource/episode-4-pharmacotherapy-development-and-trends-in-lipidology-an-expert-discussion/ 2026-07-14T17:58:46+00:00 https://www.lipid.org/resource/pregnancy-lipid-effect-ascvd-risk-management-oct-2023/ 2026-06-17T20:55:01+00:00 https://www.lipid.org/resource/prevention-of-ad-what-the-lipidologist-needs-to-know-jun-2023/ 2026-06-17T20:54:55+00:00 https://www.lipid.org/resource/statin-intolerance-a-vexing-and-elusive-clinical-problem-apr-2023/ 2026-06-17T20:54:47+00:00 https://www.lipid.org/resource/the-lipid-panel-diabetes-and-ascvd-risk-jan-2025/ 2026-06-17T20:54:05+00:00 https://www.lipid.org/resource/the-lipid-panel-adolescent-with-combined-hyperlipidemia-and-elevated-transaminases-jun-2023/ 2026-06-17T20:53:52+00:00 https://www.lipid.org/resource/clinical-utility-of-inflammatory-markers-and-advanced-lipoprotein-testing-advice-from-an-expert-panel-of-lipid-specialists/ 2026-06-16T15:45:27+00:00 https://www.lipid.org/resource/nla-recommendations-for-patient-centered-management-of-dyslipidemia/ 2026-06-16T15:45:18+00:00 https://www.lipid.org/resource/update-on-familial-hypercholesterolemia-an-expert-clinical-consensus-from-the-national-lipid-association/ 2026-06-16T15:42:26+00:00 https://www.lipid.org/resource/multidisciplinary-teams-in-clinical-lipidology-and-cardiometabolic-care-a-national-lipid-association-expert-clinical-review/ 2026-06-16T15:36:42+00:00 https://www.lipid.org/resource/familial-chylomicronemia-syndrome-an-expert-clinical-review-from-the-national-lipid-association/ 2026-06-16T15:35:21+00:00 https://www.lipid.org/resource/managing-hypercholesterolemia-in-adults-older-than-75-years-without-a-history-of-atherosclerotic-cardiovascular-disease-an-expert-clinical-consensus-from-the-national-lipid-association-and-the-ameri/ 2026-06-16T15:32:21+00:00 https://www.lipid.org/resource/recognition-and-management-of-persistent-chylomicronemia-a-joint-expert-clinical-consensus-by-the-national-lipid-association-and-the-american-society-for-preventive-cardiology/ 2026-06-16T15:30:59+00:00 https://www.lipid.org/resource/role-of-apolipoprotein-b-in-the-clinical-management-of-cardiovascular-risk-in-adults-an-expert-clinical-consensus-from-the-national-lipid-association/ 2026-06-16T15:28:39+00:00 https://www.lipid.org/resource/a-focused-update-to-the-2019-nla-scientific-statement-on-use-of-lipoproteina-in-clinical-practice/ 2026-06-16T15:24:56+00:00 https://www.lipid.org/resource/nutrition-interventions-for-adults-with-dyslipidemia-a-clinical-perspective-from-the-national-lipid-association/ 2026-06-16T15:22:47+00:00 https://www.lipid.org/resource/the-importance-of-low-density-lipoprotein-cholesterol-measurement-and-control-as-performance-measures-a-joint-clinical-perspective-from-the-national-lipid-association-and-the-american-society-for-pre/ 2026-06-16T15:21:24+00:00 https://www.lipid.org/resource/assessment-and-management-of-statin-associated-muscle-symptoms-sams-a-clinical-perspective-from-the-national-lipid-association/ 2026-06-16T15:19:52+00:00 https://www.lipid.org/resource/prevention-of-atherosclerotic-cardiovascular-disease-in-south-asians-in-the-us-a-clinical-perspective-from-the-national-lipid-association/ 2026-06-16T15:12:38+00:00 https://www.lipid.org/resource/the-national-lipid-association-scientific-statement-on-coronary-artery-calcium-cac-scoring-to-guide-preventive-strategies-for-ascvd-risk-reduction/ 2026-06-16T15:08:30+00:00 https://www.lipid.org/resource/enhancing-the-value-of-pcsk9-monoclonal-antibodies-by-identifying-patients-most-likely-to-benefit-a-consensus-statement-from-the-national-lipid-association/ 2026-06-16T15:01:54+00:00 https://www.lipid.org/resource/the-importance-of-non-hdl-cholesterol-reporting-in-lipid-management/ 2026-06-16T14:43:03+00:00 https://www.lipid.org/resource/national-lipid-association-scientific-statement-on-the-use-of-icosapent-ethyl-in-statin-treated-patients-with-elevated-triglycerides-and-high-or-very-high-ascvd-risk/ 2026-06-16T14:36:29+00:00 https://www.lipid.org/resource/lipids-dyslipidemia-what-clinicians-need-to-know/ 2026-06-11T18:36:11+00:00 https://www.lipid.org/wp-content/uploads/Lipoprotein-Photo-scaled-1-scaled.jpg https://www.lipid.org/resource/practical-pearls-palisade-trial-and-plozasiran-a-new-triglyceride-lowering-drug-feb-2025/ 2026-06-10T22:15:09+00:00 https://www.lipid.org/resource/practical-pearls-tg-targets-apoc3-angptl3-jun-2025/ 2026-06-10T22:14:57+00:00 https://www.lipid.org/resource/practical-pearls-promoting-lipoproteina-awareness-and-testing-for-risk-feb-2026/ 2026-06-10T22:14:47+00:00 https://www.lipid.org/resource/practical-pearls-lipoproteina-in-focus-current-knowledge-approach-to-patient-care-may-2025/ 2026-06-10T22:14:37+00:00 https://www.lipid.org/resource/the-lipid-panel-cardiovascular-risk-equations-and-prediction-of-ascvd-risk-jun-2025/ 2026-06-10T22:13:45+00:00 https://www.lipid.org/resource/the-lipid-panel-pharmacology-what-clinicians-should-know-may-2025/ 2026-06-10T22:13:17+00:00 https://www.lipid.org/resource/the-lipid-panel-lpa-today-and-tomorrow-apr-2025/ 2026-06-10T22:13:06+00:00 https://www.lipid.org/resource/the-lipid-panel-cad-what-is-plaque-how-do-we-measure-and-why-mar-2025/ 2026-06-10T22:12:48+00:00 https://www.lipid.org/resource/the-lipid-panel-hypertriglyceridemia-in-patients-with-t2dm-feb-2025/ 2026-06-10T22:12:34+00:00 https://www.lipid.org/resource/the-lipid-panel-pediatrics-oct-2024/ 2026-06-10T22:12:01+00:00 https://www.lipid.org/resource/the-lipid-panel-glp-1-receptor-agonists-weight-loss-cardiometabolic-health-apr-2024/ 2026-06-10T22:11:51+00:00 https://www.lipid.org/resource/the-lipid-panel-coronary-artery-calcium-mar-2024/ 2026-06-10T22:10:40+00:00 https://www.lipid.org/resource/the-lipid-panel-womens-heart-health-feb-2024/ 2026-06-10T22:10:32+00:00 https://www.lipid.org/resource/the-lipid-panel-lipoproteina-jan-2024/ 2026-06-10T22:10:23+00:00 https://www.lipid.org/resource/the-lipid-panel-non-alcoholic-fatty-liver-disease-dec-2023/ 2026-06-10T22:10:10+00:00 https://www.lipid.org/resource/the-lipid-panel-the-care-of-the-diabetic-patient-the-role-of-glp1-nov-2023/ 2026-06-10T22:09:35+00:00 https://www.lipid.org/resource/statin-intolerance-statin-defiance-nocebo-effect-does-it-really-matter-jan-2024/ 2026-06-10T22:08:07+00:00 https://www.lipid.org/resource/is-there-a-role-for-aspirin-in-prevention-in-2022/ 2026-06-10T22:06:55+00:00 https://www.lipid.org/resource/the-impact-of-sodium-glucose-co-transporter-2-inhibitors-on-lipid-profile/ 2026-06-10T22:06:20+00:00 https://www.lipid.org/wp-content/uploads/LL1-1.png https://www.lipid.org/resource/therapies-for-treating-hypertriglyceridemia/ 2026-06-10T22:05:14+00:00 https://www.lipid.org/resource/obesity-and-cardiometabolic-risk-in-american-indian-youth/ 2026-06-10T22:03:40+00:00 https://www.lipid.org/resource/case-study-rural-healthcare-inequities/ 2026-06-10T22:02:45+00:00 https://www.lipid.org/wp-content/uploads/Dimick.png https://www.lipid.org/resource/navigating-a-food-desert/ 2026-06-10T22:02:22+00:00 https://www.lipid.org/wp-content/uploads/Rychlik-1.png https://www.lipid.org/wp-content/uploads/Rychlik-2.png https://www.lipid.org/resource/practical-tips-on-testosterone-replacement-therapy-dec-2023/ 2026-06-10T21:59:35+00:00 https://www.lipid.org/resource/cardiovascular-disease-in-the-rural-american-population/ 2026-06-10T21:58:34+00:00 https://www.lipid.org/wp-content/uploads/Nwizu-1.png https://www.lipid.org/wp-content/uploads/Nwizu-2.png https://www.lipid.org/wp-content/uploads/Nwizu-3.png https://www.lipid.org/resource/differences-in-statin-metabolism-in-east-asians/ 2026-06-10T21:56:26+00:00 https://www.lipid.org/wp-content/uploads/SC-A.png https://www.lipid.org/wp-content/uploads/SC-B.png https://www.lipid.org/resource/management-of-hypertriglyceridemia-in-a-patient-considered-an-undocumented-immigrant/ 2026-06-10T21:55:41+00:00 https://www.lipid.org/resource/tools-for-alleviating-drug-disparities-in-lipidology/ 2026-06-10T21:55:14+00:00 https://www.lipid.org/wp-content/uploads/PP-A.png https://www.lipid.org/resource/understanding-differences-in-ascvd-risk-and-outcomes-in-south-asians/ 2026-06-10T21:54:41+00:00 https://www.lipid.org/wp-content/uploads/LL-A.png https://www.lipid.org/wp-content/uploads/LL-B.png https://www.lipid.org/resource/racial-and-ethnic-differences-associated-with-disparities-in-lipidology/ 2026-06-10T21:52:25+00:00 https://www.lipid.org/wp-content/uploads/ferd1.png https://www.lipid.org/resource/bempedoic-acid-therapy-for-patients-with-statin-intolerance/ 2026-06-10T21:24:00+00:00 https://www.lipid.org/wp-content/uploads/BA-in-Statin-Intolerant-Review1.png https://www.lipid.org/wp-content/uploads/Full-Table.jpg https://www.lipid.org/resource/clinician-strategies-for-facilitating-lifestyle-changes-during-covid-19-and-beyond/ 2026-06-10T21:23:34+00:00 https://www.lipid.org/wp-content/uploads/Specialty-Table-1.jpg https://www.lipid.org/wp-content/uploads/Specialty-Table-2.jpg https://www.lipid.org/wp-content/uploads/Specialty-Table-3.jpg https://www.lipid.org/resource/case-study-role-of-sodium-glucose-cotransporter-2-inhibitors-in-managing-residual-cardiovascular-risk/ 2026-06-10T21:23:02+00:00 https://www.lipid.org/wp-content/uploads/Case-Table-1.jpg https://www.lipid.org/wp-content/uploads/Case-Table-2.jpg https://www.lipid.org/wp-content/uploads/Case-Figure-1.jpg https://www.lipid.org/resource/the-use-of-colchicine-for-secondary-cardiovascular-disease-prevention-whats-old-is-new-again/ 2026-06-10T21:22:32+00:00 https://www.lipid.org/wp-content/uploads/LL-Table-1.jpg https://www.lipid.org/wp-content/uploads/LL-Table-2.jpg https://www.lipid.org/resource/machine-learning-to-detect-cardiovascular-complications-of-covid-19/ 2026-06-10T21:22:02+00:00 https://www.lipid.org/wp-content/uploads/Table-11.jpg https://www.lipid.org/resource/non-lipid-lowering-therapies-impacting-cardiovascular-disease-risk/ 2026-06-10T21:21:38+00:00 https://www.lipid.org/resource/lipoproteina-and-its-role-in-cardiovascular-risk/ 2026-06-10T21:18:33+00:00 https://www.lipid.org/wp-content/uploads/Case-Study-Figure-1.jpg https://www.lipid.org/resource/renewed-justification-for-triglyceride-lowering-therapy-insight-from-reduce-it-and-previous-fibrate-trials/ 2026-06-10T21:17:43+00:00 https://www.lipid.org/resource/finding-familial-hypercholesterolemia-in-the-perinatal-period/ 2026-06-10T21:17:14+00:00 https://www.lipid.org/resource/the-effects-of-testosterone-therapy-in-females-on-lipid-parameters-and-cardiovascular-disease-risk/ 2026-06-10T21:16:14+00:00 https://www.lipid.org/wp-content/uploads/Specialty-Corner-1.jpg https://www.lipid.org/wp-content/uploads/Specialty-Corner-2-top.jpg https://www.lipid.org/wp-content/uploads/Specialty-Corner-2-Bottom.jpg https://www.lipid.org/wp-content/uploads/Specialty-Corner-3.jpg https://www.lipid.org/resource/case-study-type-1-diabetes-familial-hypercholesterolemia-and-elevated-lipoproteina/ 2026-06-10T21:15:57+00:00 https://www.lipid.org/wp-content/uploads/Table-1-Case-Study.jpg https://www.lipid.org/wp-content/uploads/Table-2-Case-Study.jpg https://www.lipid.org/wp-content/uploads/Table-3-Case-Study.jpg https://www.lipid.org/resource/motivation-from-failure/ 2026-06-10T21:15:24+00:00 https://www.lipid.org/resource/statins-and-brain-fog-confusing-for-patients-prescribers-and-me/ 2026-06-10T21:14:54+00:00 https://www.lipid.org/resource/elevated-and-dysfunctional-hdl/ 2026-06-10T21:14:34+00:00 https://www.lipid.org/resource/icosapent-ethyl-treated-hypertriglyceridemia-to-reduce-ascvd-residual-risk/ 2026-06-10T21:14:16+00:00 https://www.lipid.org/wp-content/uploads/EBM-Table.jpg https://www.lipid.org/resource/the-unique-south-asian-phenotype-and-opportunities-for-early-intervention-to-prevent-diabetes-and-ascvd/ 2026-06-10T21:12:27+00:00 https://www.lipid.org/wp-content/uploads/Clinical-Feature-Table.jpg https://www.lipid.org/resource/genetic-testing-in-dyslipidemia/ 2026-06-10T21:11:59+00:00 https://www.lipid.org/resource/postprandial-dysmetabolism-understanding-the-impact-of-elevated-postprandial-glucose-and-triglycerides-with-the-potential-to-prevent-or-intervene-early/ 2026-06-10T21:10:25+00:00 https://www.lipid.org/resource/motivational-interviewing-to-promote-behavior-change/ 2026-06-10T21:05:52+00:00 https://www.lipid.org/resource/best-biomarkers-for-inflammation/ 2026-06-10T21:05:14+00:00 https://www.lipid.org/resource/high-sensitivity-c-reactive-protein-versus-coronary-artery-calcium-scoring-dissecting-a-biological-target-from-a-cardiovascular-risk-assessment-tool/ 2026-06-10T21:04:40+00:00 https://www.lipid.org/resource/a-glimpse-at-lipodystrophy-diagnosis-and-treatment/ 2026-06-10T21:04:19+00:00 https://www.lipid.org/wp-content/uploads/Spin_Final_p015.jpg https://www.lipid.org/wp-content/uploads/Spin_Final_p016.jpg https://www.lipid.org/resource/management-of-statin-treatment-in-adult-solid-organ-transplant-recipients/ 2026-06-10T21:03:44+00:00 https://www.lipid.org/wp-content/uploads/f-42-1.jpg https://www.lipid.org/wp-content/uploads/f-42-2.jpg https://www.lipid.org/resource/the-important-role-of-lipidologists-in-dispelling-ascvd-treatment-myths-among-special-populations/ 2026-06-10T21:01:54+00:00 https://www.lipid.org/resource/diet-and-disparities/ 2026-06-10T21:01:12+00:00 https://www.lipid.org/wp-content/uploads/Sample-Recipes.png https://www.lipid.org/wp-content/uploads/Check-Unit-Price.png https://www.lipid.org/resource/the-predimed-study-should-the-mediterranean-diet-be-recommended-to-prevent-cardiovascular-disease/ 2026-06-10T21:00:50+00:00 https://www.lipid.org/resource/healthy-dietary-patterns-not-specific-nutrient-targets/ 2026-06-10T21:00:38+00:00 https://www.lipid.org/resource/coffee-and-your-health-should-you-have-a-little-or-a-latte/ 2026-06-10T21:00:25+00:00 https://www.lipid.org/resource/evaluation-of-women-for-the-primary-prevention-of-atherosclerotic-cardiovascular-disease/ 2026-06-10T20:50:53+00:00 https://www.lipid.org/resource/statins-for-primary-prevention-in-women-how-an-individual-benefit-model-could-expand-treatment-to-hypercholesterolemic-women-under-age-65-with-10-year-ascvd-risk-less-than-7-5/ 2026-06-10T20:49:41+00:00 https://www.lipid.org/wp-content/uploads/Table11.png https://www.lipid.org/wp-content/uploads/Figure1.png https://www.lipid.org/wp-content/uploads/Figure2.png https://www.lipid.org/resource/hormone-replacement-therapy-and-cardiovascular-risk/ 2026-06-10T20:48:54+00:00 https://www.lipid.org/resource/conventional-and-non-conventional-treatment-options-for-post-menopausal-symptoms/ 2026-06-10T20:48:26+00:00 https://www.lipid.org/wp-content/uploads/Table12.png https://www.lipid.org/resource/severe-hypertriglyceridemia-in-a-40-year-old-woman-using-the-apob-app-to-confirm-a-diagnosis-and-target-future-cardiovascular-risk/ 2026-06-10T20:48:00+00:00 https://www.lipid.org/wp-content/uploads/Table13.png https://www.lipid.org/wp-content/uploads/Figure1-4.png https://www.lipid.org/resource/management-of-hypercholesterolemia-in-young-women-of-childbearing-years-and-during-pregnancy/ 2026-06-10T20:47:26+00:00 https://www.lipid.org/resource/cardiovascular-nutrition-fads-and-controversies/ 2026-06-10T16:52:02+00:00 https://www.lipid.org/resource/the-lipid-and-cardiovascular-disease-specialist-and-the-use-of-basic-statistics-reader-beware/ 2026-06-10T16:51:39+00:00 https://www.lipid.org/resource/eicosapentaenoic-acid-pleiotrope-extraordinaire/ 2026-06-10T16:48:22+00:00 https://www.lipid.org/resource/targeting-atherogenic-cholesterol-goals-for-patients-that-meet-the-criteria-of-extreme-ascvd-risk/ 2026-06-10T16:47:54+00:00 https://www.lipid.org/wp-content/uploads/acohort.jpg https://www.lipid.org/wp-content/uploads/allcausemortality.jpg https://www.lipid.org/wp-content/uploads/accumlatingevidence.jpg https://www.lipid.org/wp-content/uploads/riskcat.jpg https://www.lipid.org/resource/case-study-statin-use-in-the-elderly-an-age-old-question/ 2026-06-10T16:46:55+00:00 https://www.lipid.org/resource/my-statin-or-my-sarcolemma-could-vitamin-d-provide-some-answers-for-improved-statin-compliance/ 2026-06-10T16:46:37+00:00 https://www.lipid.org/wp-content/uploads/bloodvessellipid1.png https://www.lipid.org/wp-content/uploads/mystatintable.png https://www.lipid.org/resource/age-related-pharmacokinetic-changes-and-the-impact-on-statin-therapy-in-older-patients/ 2026-06-10T16:46:16+00:00 https://www.lipid.org/resource/from-microbes-to-foam-cells/ 2026-06-10T16:45:58+00:00 https://www.lipid.org/resource/the-use-of-statins-to-reduce-cardiovascular-risk-in-the-elderly/ 2026-06-10T16:43:02+00:00 https://www.lipid.org/resource/risk-factors-and-lifestyle-considerations-in-older-adults/ 2026-06-10T16:42:46+00:00 https://www.lipid.org/wp-content/uploads/lipidgraph1.png https://www.lipid.org/resource/nutrition-recommendations-and-disorders-of-lipid-metabolism-untangling-the-confusion-among-consumers-and-healthcare-providers/ 2026-06-10T16:33:51+00:00 https://www.lipid.org/wp-content/uploads/Table-1-Karmally.png https://www.lipid.org/resource/dietary-trans-fatty-acids-and-cardiovascular-disease-risk-should-we-go-back-to-using-butter/ 2026-06-10T16:33:17+00:00 https://www.lipid.org/wp-content/uploads/Figure-1-Burke.png https://www.lipid.org/wp-content/uploads/Table-1-Burke.png https://www.lipid.org/resource/chelation-therapy-is-a-proven-treatment-for-cardiovascular-disease-myth-or-fact/ 2026-06-10T16:32:04+00:00 https://www.lipid.org/resource/worsening-lipoproteins-on-a-low-carb-diet/ 2026-06-10T16:31:47+00:00 https://www.lipid.org/wp-content/uploads/Guest-Ed-Figure.bmp https://www.lipid.org/resource/an-evidence-based-approach-to-sitosterolemia/ 2026-06-10T16:30:57+00:00 https://www.lipid.org/resource/lysosomal-acid-lipase-deficiency-lal-d/ 2026-06-10T16:30:02+00:00 https://www.lipid.org/wp-content/uploads/Friedrich-Table-1.jpg https://www.lipid.org/resource/dyslipidemia-antipsychotic-medications-who-is-monitoring-the-lipids/ 2026-06-10T16:29:23+00:00 https://www.lipid.org/wp-content/uploads/Croy-Table-1.jpg https://www.lipid.org/wp-content/uploads/Croy-Table-2.jpg https://www.lipid.org/wp-content/uploads/Croy-Table-3.jpg https://www.lipid.org/resource/effects-of-post-transplant-drugs-on-lipids-and-treatment-options/ 2026-06-10T16:28:17+00:00 https://www.lipid.org/wp-content/uploads/table1-15.png https://www.lipid.org/wp-content/uploads/table2-16.png https://www.lipid.org/wp-content/uploads/figure1-17.png https://www.lipid.org/resource/apo-a1-remnant-ratio/ 2026-06-10T16:26:23+00:00 https://www.lipid.org/resource/statins-in-chronic-kidney-disease-and-dialysis-clinical-trials-mechanisms-dosing-and-treatment-recommendations/ 2026-06-10T16:26:05+00:00 https://www.lipid.org/wp-content/uploads/Table-1-Lerma.jpg https://www.lipid.org/resource/dyslipidemia-in-the-patient-living-with-hiv/ 2026-06-10T16:25:02+00:00 https://www.lipid.org/resource/real-world-data-from-patients-at-high-cardiovascular-risk-for-a-first-mi-or-stroke/ 2026-06-10T16:21:36+00:00 https://www.lipid.org/wp-content/uploads/Real-World-Data-From-Patients-at-High-CV-Risk-Without-a-Prior-MI-or-Stroke-Amgen-1.png https://www.lipid.org/resource/getting-the-e-patient-equipped-and-engaged/ 2026-06-10T16:18:34+00:00 https://www.lipid.org/resource/expert-guidelines-at-a-glance-acute-pancreatitis-elevated-triglycerides/ 2026-06-10T16:07:28+00:00 https://www.lipid.org/wp-content/uploads/Acute-Pancreatitis-Elevated-Triglycerides-Arrowhead-Pharmaceuticals-1.png https://www.lipid.org/resource/telemedicine-and-the-patient-experience/ 2026-06-10T16:04:19+00:00 https://www.lipid.org/resource/the-palms-of-rare-lipid-disorders/ 2026-06-10T15:58:55+00:00 https://www.lipid.org/wp-content/uploads/Dr_-Amhad-images1.jpg https://www.lipid.org/resource/heterozygous-familial-hypobetalipoproteinemia-case-study-and-literature-review/ 2026-06-10T15:57:31+00:00 https://www.lipid.org/wp-content/uploads/figure1-12.png https://www.lipid.org/resource/tolerability-of-statin-therapy-in-children/ 2026-06-10T15:49:42+00:00 https://www.lipid.org/resource/case-study-muscle-related-statin-intolerance/ 2026-06-10T15:48:45+00:00 https://www.lipid.org/resource/managing-the-statin-intolerant-patient-low-dose-low-frequency-treatment-regimens/ 2026-06-10T15:48:01+00:00 https://www.lipid.org/wp-content/uploads/chart1-09.png https://www.lipid.org/wp-content/uploads/table1-09.png https://www.lipid.org/wp-content/uploads/table2-09.png https://www.lipid.org/resource/recognition-and-treatment-for-fabrys-disease-and-morquio-a-syndrome/ 2026-06-10T15:47:11+00:00 https://www.lipid.org/resource/hypertriglyceridemia-and-the-risk-of-cardiovascular-disease-and-pancreatitis-in-a-veteran-population/ 2026-06-10T15:45:11+00:00 https://www.lipid.org/wp-content/uploads/Copeland.png https://www.lipid.org/resource/lipid-spin/summer-2022/the-lipid-hypothesis/ 2026-06-10T15:44:20+00:00 https://www.lipid.org/resource/inclisiran-where-will-it-fit/ 2026-06-10T15:43:38+00:00 https://www.lipid.org/resource/enzymes-in-the-gut-microbiome-as-contributors-to-circulating-lipids/ 2026-06-10T15:40:53+00:00 https://www.lipid.org/resource/lipoprotein-a-medications-under-development/ 2026-06-10T15:40:00+00:00 https://www.lipid.org/wp-content/uploads/SC1-1.png https://www.lipid.org/resource/adulting-guidance-for-transitioning-patients-from-pediatric-to-adult-lipid-clinics/ 2026-06-10T15:37:14+00:00 https://www.lipid.org/wp-content/uploads/Selection-of-Therapeutics-9-2.png https://www.lipid.org/wp-content/uploads/Tips-for-Adult-Provider-9-2.png https://www.lipid.org/resource/case-study-glucagon-like-peptide-1-glp-1-receptor-agonists-in-the-treatment-of-obesity/ 2026-06-10T15:36:00+00:00 https://www.lipid.org/resource/aha-scientific-statement-on-nonalcoholic-fatty-liver-disease/ 2026-06-10T15:35:31+00:00 https://www.lipid.org/wp-content/uploads/Table-1-_-LL.png https://www.lipid.org/wp-content/uploads/Table-2-_-LL.png https://www.lipid.org/wp-content/uploads/Table-3-_-LL.png https://www.lipid.org/resource/lipid-spin/summer-2022/the-care-team-focus/ 2026-06-10T15:33:42+00:00 https://www.lipid.org/resource/the-lipid-panel-hypertriglyceridemia-oct-2022/ 2026-06-10T15:31:05+00:00 https://www.lipid.org/resource/the-lipid-panel-familial-hypercholesterolemia-sep-2022/ 2026-06-10T15:30:41+00:00 https://www.lipid.org/resource/cardiometabolic-syndrome-a-package-deal/ 2026-06-10T15:30:12+00:00